288 related articles for article (PubMed ID: 19193059)
1. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
[TBL] [Abstract][Full Text] [Related]
2. Potent antagonist for the vitamin D receptor: vitamin D analogues with simple side chain structure.
Sakamaki Y; Inaba Y; Yoshimoto N; Yamamoto K
J Med Chem; 2010 Aug; 53(15):5813-26. PubMed ID: 20608741
[TBL] [Abstract][Full Text] [Related]
3. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
[TBL] [Abstract][Full Text] [Related]
4. Butyl pocket formation in the vitamin D receptor strongly affects the agonistic or antagonistic behavior of ligands.
Yoshimoto N; Sakamaki Y; Haeta M; Kato A; Inaba Y; Itoh T; Nakabayashi M; Ito N; Yamamoto K
J Med Chem; 2012 May; 55(9):4373-81. PubMed ID: 22512505
[TBL] [Abstract][Full Text] [Related]
5. 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor.
Yamamoto K; Inaba Y; Yoshimoto N; Choi M; DeLuca HF; Yamada S
J Med Chem; 2007 Mar; 50(5):932-9. PubMed ID: 17298045
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators.
Inaba Y; Yamamoto K; Yoshimoto N; Matsunawa M; Uno S; Yamada S; Makishima M
Mol Pharmacol; 2007 May; 71(5):1298-311. PubMed ID: 17325131
[TBL] [Abstract][Full Text] [Related]
7. An o-aminoanilide analogue of 1α,25-dihydroxyvitamin D(3) functions as a strong vitamin D receptor antagonist.
Lamblin M; Spingarn R; Wang TT; Burger MC; Dabbas B; Moitessier N; White JH; Gleason JL
J Med Chem; 2010 Oct; 53(20):7461-5. PubMed ID: 20883026
[TBL] [Abstract][Full Text] [Related]
8. 22S-butyl-1alpha,24R-dihydroxyvitamin D3: recovery of vitamin D receptor agonistic activity.
Inaba Y; Nakabayashi M; Itoh T; Yoshimoto N; Ikura T; Ito N; Shimizu M; Yamamoto K
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):146-50. PubMed ID: 20211257
[TBL] [Abstract][Full Text] [Related]
9. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
Väisänen S; Peräkylä M; Kärkkäinen JI; Steinmeyer A; Carlberg C
J Mol Biol; 2002 Jan; 315(2):229-38. PubMed ID: 11779241
[TBL] [Abstract][Full Text] [Related]
10. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor.
Gonzalez MM; Samenfeld P; Peräkylä M; Carlberg C
Mol Endocrinol; 2003 Oct; 17(10):2028-38. PubMed ID: 12843209
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain.
Belorusova AY; Martínez A; Gándara Z; Gómez G; Fall Y; Rochel N
Eur J Med Chem; 2017 Jul; 134():86-96. PubMed ID: 28399453
[TBL] [Abstract][Full Text] [Related]
13. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
González-Avión XC; Mouriño A; Rochel N; Moras D
J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Nuclear Receptor Ligands and Elucidation of Their Mechanisms of Action.
Yamamoto K
Chem Pharm Bull (Tokyo); 2019; 67(7):609-619. PubMed ID: 31257315
[TBL] [Abstract][Full Text] [Related]
15. Development of vitamin D analogs modulating the pocket structure of vitamin D receptor.
Yamamoto K; Anami Y; Itoh T
Curr Top Med Chem; 2014; 14(21):2378-87. PubMed ID: 25537068
[TBL] [Abstract][Full Text] [Related]
16. Gene regulatory potential of nonsteroidal vitamin D receptor ligands.
Peräkylä M; Malinen M; Herzig KH; Carlberg C
Mol Endocrinol; 2005 Aug; 19(8):2060-73. PubMed ID: 15860548
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
18. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
Liu YY; Nguyen C; Peleg S
Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
[TBL] [Abstract][Full Text] [Related]
20. A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group.
Anami Y; Itoh T; Egawa D; Yoshimoto N; Yamamoto K
J Med Chem; 2014 May; 57(10):4351-67. PubMed ID: 24742174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
